Records were reviewed of 82 immunocompetent children (median age, 2.5 years
) from southern Greece who were diagnosed with visceral leishmaniasis from
1986 through 1998. Forty-nine (58%) patients originated from the city of At
hens; of them, 46 (94%) lived by hills bordering the city. The median inter
val from the onset of symptoms to admission was 10 days. Fever and splenome
galy were observed in >95% of the patients. Thrombocytopenia was the most f
requent hematological finding (80%), All patients were treated with meglumi
ne antimonate; 20 (24%) of them were partially treated on an outpatient bas
is. Rapid clinical response was noted in all patients but one. Five patient
s relapsed; 3 responded to reintroduction of meglumine antimonate, 1 respon
ded to liposomal amphotericin B, and 1 underwent splenic artery ligation. W
e conclude that pentavalent antimonials remain the first choice of treatmen
t for visceral leishmaniasis in immunocompetent children in areas where res
istance has not become a problem, It is possible to treat affected patients
with outpatient administration of these agents, making them feasible optio
ns for therapy.